Mh. Sweeney et al., PERIPHERAL NEUROPATHY AFTER OCCUPATIONAL EXPOSURE TO 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN (TCDD), American journal of industrial medicine, 23(6), 1993, pp. 845-858
Reports of human exposure to 2.3,7,8-tetrachlorodibenzo-p-dioxin (TCDD
) describe signs and symptoms consistent with exposure-related periphe
ral neuropathy. In a cross-sectional study, prevalence of peripheral n
europathy was measured in 265 workers exposed 15 years earlier to chem
icals contaminated with TCDD and in 244 unexposed, age-, race-, gender
- and community-matched comparisons. Cases of peripheral neuropathy we
re defined from examination, electrophysiologic and quantitative senso
ry tests, and symptoms. Exposure was assessed by measuring lipid-adjus
ted serum TCDD levels. The mean serum TCDD level for workers (220 part
s per trillion (ppt)) was significantly higher than for referents (7 p
pt) (p < .0001). Thirty-two percent of both worker and referent groups
met the case definition for peripheral neuropathy. In the logistic re
gression analyses, serum TCDD level was not related to peripheral neur
opathy. These data suggest that despite continued high serum TCDD leve
ls, peripheral neuropathy is not a long-term sequela of high exposure
to TCDD-contaminated chemicals. However, the study cannot preclude the
occurrence and subsequent resolution of acute effects caused by high
exposure, as experienced in Seveso and possibly by some workers, while
exposed to high levels of TCDD-contaminated substances.